1 Nina Jo Muse, MD, Psychiatric Advisor State Hospital Section, Mental Health Substance Abuse Division Texas Department of State Health Services Psychotropic.

Slides:



Advertisements
Similar presentations
TREATMENT PLAN REQUIREMENTS
Advertisements

Aug 7 09 Co-Occurring Service Array Psychiatric Evaluation Comprehensive Evaluation Medication Monitoring Medications Clinical Consultation Family Therapy.
Effective Casework Practice (Foster Care) Ongoing assessment of childs needs and interventions Ongoing assessment and implementation of services/supports.
Michael W. Naylor, M.D. University of Illinois at Chicago Director, Clinical Services in Psychopharmacology.
Role of the Pharmacist in Collaborative Care for Mental Health and Addiction Treatment in Medically Underserved Appalachia Sarah T. Melton, PharmD,BCPP,CGP.
AN OUTLINE OF IT’S ROLES AND STRUCTURE IN MATTERS OF CHILD PROTECTIVE SERVICES RI’s Family Court System.
QI Initiatives for Psychotropic Use in Foster Youth in Maine Lindsey Tweed MD MPH Office of Child & Family Services; Maine DHHS
PRELIMINARY DRAFT Behavioral Health Transformation September 26, 2014 PRELIMINARY WORKING DRAFT, SUBJECT TO CHANGE.
Arkansas Children’s Behavioral Health Care Commission AR DHS Division of Medical Services Pharmacy Program Laurence H. Miller, M.D., Senior Psychiatrist.
The context:  Increase in joint planning between Alberta Health, Alberta Health Services and Human Services  Focus on children/youth involved with Child.
Drug Utilization Review (DUR)
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
1 Child Welfare Reform Council August 5, 2014 Transition of Children in Foster Care, Receiving Adoption Assistance and Select Youth in Juvenile Justice.
Behavioral Health Services for Injured or Ill workers – Collaborative Care Analysis and Recommendations January 22, 2015.
Consent for Psychotropic Medication
Behavioral Health Screening & Referral in Pediatric Clinics
Illinois Children’s Healthcare Foundation CHILDREN’S MENTAL HEALTH INITIATIVE Building Systems of Care: Community by Community Fostering Creativity Through.
Collaborative Mental Health Care Pilot Program Bidder’s Conference October 27, 2014.
May 17, 2012 Electronic Information Exchange for Children in Foster Care Beth Morrow Director, Health IT Initiatives The Children’s Partnership Congressional.
“Psychotropic medications and children: science, Law, and Policy” UC Hastings college of law symposium on children’s health, mental health & the law March.
Missouri’s Primary Care and CMHC Health Home Initiative
The CHIPRA Pediatric Quality Measures Program: Health Information Technology and Patient Safety Edwin Lomotan, MD, FAAP Office of Extramural Research,
Foster Care Electronic Health Record Large-Scale Applicability Kay Ghahremani Medicaid/CHIP Director for Policy Development October 2011.
Thomas I. Mackie, MA, MPH Tufts Clinical and Translational Science Institute Tufts University Boston, MA.
Big Strides for Small Patients: Developmental Screening in Pediatric Primary Care Department of Pediatrics Jerold Stirling, MD Rebecca Turk, MD Melanie.
Clinical Management for Behavioral Health Services (CMBHS)
1 Informed Consent and Monitoring of Psychotropic Medications in Texas Kathy Teutsch, RN, LMSW-MSSW: CPS Division Administrator for Medical Services SHARED.
11 Understanding and Improving the Quality of Psychotropic Management and Mental Health Services for Foster Youth: Metric-Driven State QI Strategies Stephen.
IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013.
Psychoactive drugs and New Child Psychiatric services for Wyoming James Bush MD, FACP Medicaid Medical Director Wyoming Dept of Health August 27-28,2012.
Lessons Learned from Psychotropic Medication Monitoring for Texas Foster Children A joint project of Texas Department of Family and Protective Services.
Medicaid Mental Health Benefits Overview of Coverage, Service Delivery and Utilization Mental Health and Substance Abuse Interim Committee Meeting August.
1 Anti-psychotic Medication in Children, Adolescents and Foster Care: Too Many, too Much, and too Young Medicaid Medical Directors Learning Network (MMDLN)
“Reaching across Arizona to provide comprehensive quality health care for those in need” Our first care is your health care Arizona Health Care Cost Containment.
L.A. Care Health Plan Behavioral Health Support Services E.E. Lazarou, MD, MS, RD Health Integrated.
PATTERNS OF PSYCHOTROPIC DRUG PRESCRIPTION BEFORE AND AFTER EVALUATION IN A SPECIALIZED OUTPATIENT PROGRAM FOR BIPOLAR DISORDERS G.Michalopoulos, J-M.
Department of Human Services
Behavioral Health Consultation Services - Pediatric a program to Support Behavioral Healthcare Practice in Pediatric Primary Care SmartCare.
Part 2 ADHD. Parents may first notice that their child loses interest in things sooner than other kids, or seems constantly “out of control” Often teachers.
Medical Homes For Children in Foster Care: A Proposal for CCNC Consideration Proposal collaboratively developed by: NC Pediatric Society Foundation & Benchmarks.
Rhode Island Health Home Initiative NASHP 24 th Annual State Health Policy Conference, October 4, 2011 Deborah J. Florio, Administrator Medicaid Division.
What Does Research Tell Us? Care Manager Roles in Depression Care.
OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.
Data Integration Efforts and Challenges Scott M. Bilder, Ph.D. Institute for Health, Health Care Policy, and Aging Research Rutgers, The State University.
M eaningful Quality Measures for Children with Behavioral Health Conditions Discussion with the NYS Conference of Local Mental Health Hygiene Directors.
Behavioral Health DATA BOOK A quarterly reference to community mental health and substance abuse services Fiscal Year 2015 Quarter 1 March 10, 2015
Georgia Department of Human Services Medical Director Update Presenter: Debora S. Johnson, MD Presentation to: DHS Board of Directors Date: December 9,
1. Lori Fuller, Bureau Chief CFSD Fernando Sandoval, Manager II CCLD 2.
“Focusing on the Process” Jeff Schmidt MD.  Recommendation #1: Children ages 4-18 who present with academic underachievement, behavior problems or.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
PediPRN Pediatric Psychiatry Resource Network
Medicaid ER Budget Proviso
PediPRN Pediatric Psychiatry Resource Network
Behavioral Health Integration in Texas
Foster Care Managed Care Program
Community Mental Health Authority of Clinton, Eaton, Ingham Counties
Systematic Reviews and Medical Policy Determinations
Bruce Waslick, MD Medical Director UMass / Baystate MCPAP Team
Health Home Program Services for Patient 1st Medicaid Recipients
Health Home Program Services
Primary Care Milestone 15
The context Child welfare New World order
Concurrent Care For Children Who Are Enrolled In Hospice
Psychotropic Medication Use by Children in Texas Foster Care:
Certified Community Behavioral Health Clinic
Certified Community Behavioral Health Clinics
Rhode Island Psychiatry Resource Networks (PRN)
Rhode Island Psychiatry Resource Networks (PRN)
Behavioral Health Identification, Treatment & Referral in Primary Care
86th Legislative Session Overview
Presentation transcript:

1 Nina Jo Muse, MD, Psychiatric Advisor State Hospital Section, Mental Health Substance Abuse Division Texas Department of State Health Services Psychotropic Medication Monitoring in Texas Foster Care Presentation to Because Minds Matter: Collaborating to Strengthen Management of Psychotropic Medications for Children and Youth in Foster Care Washington, DC July 20, 2012

2 Psychotropic Medication Monitoring in Texas Foster Care Significant Events Leading to Monitoring In April 2004, the state Comptroller released a report critical of foster care in Texas. In February 2005, DFPS released the best practice guidelines: Psychotropic Medication Utilization Parameters for Foster Children. In September 2005, Senate Bill 6 created a single managed care organization for foster children with requirements for consent and monitoring of psychotropic medications. In 2006, DFPS released its first report of data on use of psychotropic medications in foster children in Texas in response to the Comptroller report. In April 2008, the single MCO (STAR Health) began for 27,000 children and young adults in foster care in Texas.

3 Psychotropic Medication Monitoring in Texas Foster Care Psychotropic Medication Parameters Current version dated December, 2010 of the Parameters, earlier versions, and the 2006 report can be found at: es/guide-psychotropic.asp es/guide-psychotropic.asp These Parameters use eight criteria to indicate a need for further review of the child’s medication regimen.

4 Psychotropic Medication Monitoring in Texas Foster Care Criteria for Review of the Medication Regimen 1.Absence of a thorough assessment of DSM-IV diagnosis in the child’s medical record. 2.Five (5) or more psychotropic medications prescribed concomitantly. 3.Prescribing of: Two (2) or more antidepressants at the same time Two (2) or more antipsychotic medications at the same time Two (2) or more stimulant medications at the same time Three (3) or more mood stabilizer medications at the same time

5 Psychotropic Medication Monitoring in Texas Foster Care Review Criteria (Continued) 4.The prescribed psychotropic medication is not consistent with appropriate care for the patient’s diagnosed mental disorder or with documented target symptoms. 5.Multiple psychotropic medications for a given mental disorder are prescribed before utilizing a single medication. 6.The psychotropic medication dose exceeds usually recommended doses.

6 Psychotropic Medication Monitoring in Texas Foster Care Review Criteria (Continued) 7.Psychotropic medications are prescribed for children of very young age, including children receiving the following medications with an age of: Antidepressants:Less than four (4) years of age Antipsychotics:Less than four (4) years of age Psychostimulants:Less than three (3) years of age 8.Prescribing by a primary care provider for a diagnosis other than the following (unless recommended by a psychiatrist consultant): Attention Deficit Hyperactive Disorder (ADHD) Uncomplicated anxiety disorders Uncomplicated depression

7 Psychotropic Medication Monitoring in Texas Foster Care Use of Review Criteria with Data in Monitoring Sources of data –Medicaid office visit claims for physician services for foster children –Pharmacy claims –The medical record –The Health Passport (since April, 2008 ) Development of algorithms to sort claims data –Definitions of psychotropic, medication classes, “on the medication,” polypharmacy, concurrent –Techniques to handle the passage of time, fiscal years, and age Uses and interpretation of claims data for monitoring –10,000 foot view vs. on-the-ground view –Policy-making vs. clinical oversight –Retrospective vs. concurrent (vs. prospective reviews)

8 Psychotropic Medication Monitoring in Texas Foster Care Limitations in the Use of Claims Data Limitations due to the sources of the data –Reconciliation of physician services claims with pharmacy claims –Claims data is NOT clinical data –Service claims do not capture all diagnoses nor all services rendered –Pharmacy fill data does not tell you who is taking what, how much, for how long, or for what purpose A million ways to slice the data cake: Limitations in the sort algorithms –“What’s in a name?” Definitions of psychotropic, medication classes, “on the medication,” polypharmacy, all skew the data one way or another –Time flies or “What age is this kid really?” Misuses and misinterpretation of data –Claims data only tell you trends and/or where to look next –Make no decisions based solely upon the surface of the data

9 Psychotropic Medication Monitoring in Texas Foster Care Features of STAR Health MCO Medical home model (PCP) Expedited enrollment Coordination of physical and behavioral health (Service Management Teams) Provision of preventive care (Texas Health Steps) Broad network of providers 24/7 nursing and behavioral help-line Medical advisory committees to monitor the provision of the healthcare Health Passport for continuity of care

10 Psychotropic Medication Monitoring in Texas Foster Care Health Passport Operational on April 1, 2008 for access by state staff, network providers and medical consenters Secure, web-based electronic health record (EHR) system Accessed at (follow the link to “sign-up”) Provides access by authorized users according to their role Initially populated with two years of Medicaid and CHIP claims history and pharmacy data When the child leaves foster care, the Passport is available in electronic or printed formats to: child’s legal guardian, managing conservator, or parent child if at least 18 years of age or an emancipated minor

11 Psychotropic Medication Monitoring in Texas Foster Care Psychotropic Medication Utilization Review (PMUR) Process Health screenings – STAR Health Service Managers conduct phone interviews with caretakers to identify those children who have medication regimens which appear to be outside of the Psychotropic Medication Utilization Parameters prescribing criteria. Automated pharmacy claims screening – STAR Health also conducts a real time automated screening program utilizing pharmacy claims information from vendor drug to identify foster children who have medication regimens which may fall outside the prescribing criteria. External request – CPS Nurse specialists, CPS caseworkers, CASA volunteers, foster parents, attorneys or Child Placing Agencies can request a medication review. Court request – Family court judges can request a review to answer questions about a foster child’s medication regimen. Update on the Use of Psychoactive Medication in Texas Foster Children Fiscal Year can be found at:

Psychotropic Medication Monitoring in Texas Foster Care PMUR Process (continued) Psychotropic Medication Utilization Review (PMUR) – process by which all the children's psychotropic medication regimens "outside of Parameters" are reviewed and managed through STAR Health child psychiatrist consultations to the prescribing physicians Quality of Care Review (QOC) – physicians with practice patterns of concern (identified through the PMUR process or by complaints by parties involved in the child's care) are thoroughly reviewed and may, if warranted, be referred to the STAR Health Credentialing Committee for further investigation and disciplinary action including termination from the network 12

13 Psychotropic Medication for Children in Texas Foster Care Fiscal Years

Psychotropic Medication Monitoring in Texas Foster Care 14 Texas Foster Care SFY04 to SFY11: Psychotropic Prescriptions Greater than 60 days by Drug Class

15 Psychotropic Medication Monitoring in Texas Foster Care The Future of Monitoring in Texas Revising the Parameters review criteria and improved monitoring –Revision of indications, dosing, and age guidelines to reflect latest research –Decrease total number of meds that trigger polypharmacy review –Decrease ages that trigger review –Improve review of dosages –Improve feedback to physicians Other entities adopting the Parameters and review criteria –Regular Medicaid for children –State Hospital system –Outpatient public mental health system –Private practitioners (spillover from their Medicaid work) –(National use—iPad App developed independently available)